| AML | acute myeloid leukemia |
| BMM | bone marrow microenvironment |
| LSCs | leukemic stem cells |
| HIF | hypoxia inducible factor |
| BM | bone marrow |
| HSCs | hematopoietic stem cells |
| PHD | prolyl hydroxylases |
| VHL | von Hippel-Lindau |
| CBP | CREB-binding protein |
| HRE | hypoxia responsive elements |
| Treg | regulatory T cells |
| STAT5 | signal transducer and activator of transcription 5 |
| VEGF | vascular endothelial growth factor |
| SDF1 | stromal cell-derived factor 1 |
| SCF | stem cell factor |
| Ang2 | angiopoietin 2 |
| Angptl | angiopoietin-likes |
| IGF-2 | insulin-like growth factor 2 |
| IGFBP | insulin-like growth factor-binding protein |
| FOXO | forkhead box O |
| CDKN | cyclin-dependent kinase inhibitor |
| ROS | reactive oxygen species |
| OXPHOS | oxidative phosphorylation |
| CML | chronic myeloid leukemia |
| TCA | tricarboxylic acid |
| UDP-GlcNAc | uridine diphosphate N-acetylglucosamine |
| UDP-GalNAc | uridine diphosphate N-acetylgalactosamine |
| 2-HG | 2-hydroxyglutarate |
| PDK1 | pyruvate dehydrogenase 1 |
| GSH | reduced glutathione |
| GSSG | oxidized glutathione |
| COX 4-1 | cytochrome C oxidase subunit 4 isoform 1 |
| COX 4-2 | cytochrome C oxidase subunit 4 isoform 2 |
| WHO | world health organization |
| OS | overall survival |
| EFS | event free survival |
| IDH | isocitrate dehydrogenase |
| α-KG | α-ketoglutarate |
| TET | ten-eleven translocation |
| SDH | succinate dehydrogenase |
| UQ | ubiquinone |
| UQH2 | ubiquinol |
| NDRG3 | N-Myc downstream-regulated 3 |
| ERK1/2 | extracellular-signal-regulated kinase 1/2 |
| GPR91 | G-protein-coupled receptor |
| mTOR | mammalian target of rapamycin |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CXCR4 | C-X-C motif chemokine receptor 4 |
| FLT3 | FMS-like tyrosine kinase 3 |
| MIF | macrophage migration factor |
| IL-8 | interleukin-8 |
| MSC | mesenchymal stromal cells |
| PI3K | phosphoinositide 3-kinase |
| PKB or AKT | protein kinase B |
| AXL | receptor tyrosine kinase |
| ITD | internal tandem duplication |
| NPM1 | nucleophosmin |
| LDH | lactate dehydrogenase |
| Ara-C | cytarabine arabinoside |
| XIAP | X-linked inhibitor of apoptosis |
| PML | promyelocytic leukemia |
| RAR- α | retinoic acid receptor-α |
| APL | acute promyelocytic leukemia |
| ATRA | trans retinoic acid |
| HAP | hypoxia-activated prodrugs |
| BCL-2 | B-cell lymphoma 2 |
| MCL-1 | myeloid cell lymphoma 1 |
| PD-L1 | programmed death ligand 1 |
| mAb | monoclonal antibody |
| MCT | monocarboxylate transporter |
| AKR1C3 | aldo-keto reductase 1C3 |
| Br-iPM | bromo-isophosphoramide mustard |